Dihydropyridazinone cardiotonics: discovery of LY195115 and elucidation of structural features necessary for optimal inotropic activity

Conference · Wed Mar 05 04:00:00 EST 1986 · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)

OSTI ID:6991691

Krushinski, J H; Hayes, J S; Beedle, E E; Pollock, G D; Wilson, H; Robertson, D W

A series of 4,5-dihydro-6-aryl-3(/sup 2/H)-pyridazinones has been examined for inotropic activity. The optimal compound of the series, LY195115 (1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-/sup 2/H-indol-2-one), is one of the most potent and long-acting oral inotropes described to date. ED/sub 50/'s of LY195115, CI-914 and milrinone after i.v. administration to pentobarbital anesthetized dogs were 6.8, 46 and 37 ..mu..g/kg, respectively. ED/sub 50/'s after oral administration to conscious dogs were 25, 1000 and 500 ..mu..g/kg, respectively. For optimal positive inotropic activity and oral bioavailability in this series, the following structural features are necessary: (1) dihydropyridazinone ring with the nitrogen unsubstituted; (2) a hydrogen-bond acceptor substituent with a sigma value of ca 0.0 para to the dihydropyridazinone moiety; and (3) additional sterically undemanding lipophilic substituents adjacent to the hydrogen-bond acceptor site.

• Research Organization: Lilly Research Labs., Indianapolis, IN
• OSTI ID: 6991691
• Report Number(s): CONF-8604222-
• Conference Information: Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:4
• Country of Publication: United States
• Language: English

Related Subjects

550201* -- Biochemistry-- Tracer Techniques
59 BASIC BIOLOGICAL SCIENCES
ANIMALS
CARDIOVASCULAR AGENTS
DEUTERIUM
DOGS
DRUGS
HYDROGEN ISOTOPES
ISOTOPE APPLICATIONS
ISOTOPES
LIGHT NUCLEI
MAMMALS
MOLECULAR STRUCTURE
NUCLEI
ODD-ODD NUCLEI
ORAL ADMINISTRATION
STABLE ISOTOPES
TRACER TECHNIQUES
VERTEBRATES